Protein phosphatase 2A Aα regulates Aβ protein expression and stability.

The Journal of Biological Chemistry
Caitlin M O'ConnorGoutham Narla

Abstract

Protein phosphatase 2A (PP2A) represses many oncogenic signaling pathways and is an important tumor suppressor. PP2A comprises three distinct subunits and forms through a highly regulated biogenesis process, with the scaffolding A subunit existing as two highly related isoforms, Aα and Aβ. PP2A's tumor-suppressive functions have been intensely studied, and PP2A inactivation has been shown to be a prerequisite for tumor formation. Interestingly, although partial loss of the Aα isoform is growth promoting, complete Aα loss has no transformative properties. Additionally, in cancer patients, Aα is found to be inactivated in a haploinsufficient manner. Using both cellular and in vivo systems, colorectal and endometrial cancer cell lines, and biochemical and cellular assays, here we examined why the complete loss of Aα does not promote tumorigenesis. CRISPR/Cas9-mediated homozygous Aα deletion resulted in decreased colony formation and tumor growth across multiple cell lines. Protein expression analysis of PP2A family members revealed that the Aα deletion markedly up-regulates Aβ protein expression by increasing Aβ protein stability. Aβ knockdown in control and Aα knockout cell lines indicated that Aβ is necessary for cell survival i...Continue Reading

References

Mar 29, 2001·Human Pathology·S PetzmannH H Popper
Jul 6, 2004·Virchows Archiv : an International Journal of Pathology·Susanna PetzmannHelmut H Popper
Sep 15, 2004·The Journal of Biological Chemistry·Stefan StrackLisa Gomez
Jun 2, 2007·Cell·Anna A SablinaWilliam C Hahn
Jul 1, 2007·Cell Adhesion & Migration·Anna A Sablina, William C Hahn
Feb 6, 2010·Proceedings of the National Academy of Sciences of the United States of America·Alison GrinthalNancy Kleckner
Dec 17, 2010·Cancer Research·Anna A SablinaWilliam C Hahn
Mar 26, 2011·The American Journal of Pathology·Ie-Ming ShihTian-Li Wang
Oct 26, 2013·Nature Protocols·F Ann RanFeng Zhang
Jul 23, 2015·Science Signaling·Sean C LittlePeter J Mohler
Oct 29, 2015·The FEBS Journal·Jaya SangodkarGoutham Narla
Feb 26, 2016·Nature Methods·UNKNOWN ORFeome Collaboration
Jun 18, 2017·Biology Open·Lisette LangeBernhard G Herrmann

❮ Previous
Next ❯

Citations

Sep 22, 2019·Oncogene·Caitlin M O'ConnorGoutham Narla
Jul 13, 2020·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Liping ChenWen Chen

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR (general)

Clustered regularly interspaced short palindromic repeats (CRISPR) are DNA sequences in the genome that are recognized and cleaved by CRISPR-associated proteins (Cas). CRISPR-Cas system enables the editing of genes to create or correct mutations. Discover the latest research on CRISPR here.

CRISPR for Genome Editing

Genome editing technologies enable the editing of genes to create or correct mutations. Clustered regularly interspaced short palindromic repeats (CRISPR) are DNA sequences in the genome that are recognized and cleaved by CRISPR-associated proteins (Cas). Here is the latest research on the use of CRISPR-Cas system in gene editing.

ASBMB Publications

The American Society for Biochemistry and Molecular Biology (ASBMB) includes the Journal of Biological Chemistry, Molecular & Cellular Proteomics, and the Journal of Lipid Research. Discover the latest research from ASBMB here.

CRISPR in Cancer

CRISPR-Cas system enables the editing of genes to create or correct mutations. Given that genome instability and mutation is one of the hallmarks of cancer, the CRISPR-Cas system is being explored to genetically alter and eliminate cancer cells. Here is the latest research.